Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): A randomised trial of 45000 donors
The Lancet Sep 25, 2017
Di Angelantonio E, et al. - A randomised trial is done to assess the impact of different inter-donation intervals on blood supply and donor health over a 2-year period. More than 2 years, more frequent donation than is standard practice in the UK collected substantially more blood without having a major effect on donors' quality of life, physical activity, or cognitive function, but resulted in more donation-related symptoms, deferrals, and iron deficiency.
Methods
- For this study, they conducted a parallel group, pragmatic, randomised trial.
- In this trial, they selected whole blood donors aged 18 years or older from 25 centers across England, UK.
- By utilization of a computer-based algorithm, men were randomly assigned (1:1:1) to 12-week (standard) versus 10-week versus 8-week inter-donation intervals, and women were randomly assigned (1:1:1) to 16-week (standard) versus 14-week versus 12-week intervals.
- Participants were not masked to their allocated intervention group.
- The primary outcome was the number of donations more than 2 years.
- Secondary outcomes related to safety were the quality of life, symptoms potentially associated with donation, physical activity, cognitive function, haemoglobin and ferritin concentrations, and deferrals because of low haemoglobin.
Results
- Between June 11, 2012 to June 15, 2014, total 45263 whole blood donors were selected.
- Out of these 45263 whole blood donors, 22466 were men and 22797 were women.
- In this study, data were investigated for 45042 (99·5%) participants.
- Men were randomly assigned to the 12-week (n=7452) versus 10-week (n=7449) versus 8-week (n=7456) groups; and women to the 16-week (n=7550) versus 14-week (n=7567) versus 12-week (n=7568) groups.
- In men, compared with the 12-week group, the mean amount of blood collected per donor over 2 years increased by 1·69 units (95% CI 1·59-1·80; approximately 795 mL) in the 8-week group and by 0·79 units (0·69-0·88; approximately 370 mL) in the 10-week group (p<0·0001 for both).
- In women, compared with the 16-week group, it increased by 0·84 units (95% CI 0·76-0·91; approximately 395 mL) in the 12-week group and by 0·46 units (0·39-0·53; approximately 215 mL) in the 14-week group (p<0·0001 for both).
- There were no significant differences in quality of life, physical activity, or cognitive function across randomised groups.
- However, more frequent donation resulted in more donation-related symptoms (eg, tiredness, breathlessness, feeling faint, dizziness, and restless legs, particularly among men [for all listed symptoms]), lower mean haemoglobin and ferritin concentrations, and more deferrals for low haemoglobin (p<0·0001 for each) than those observed in the standard frequency groups.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries